With CE Mark approval, the benefits of the MiniMed™ 780G system are now available with a new sensor that takes less than 10 seconds to insert1 DUBLIN, Jan. 8, 2024 /PRNewswire/ -- Medtronic plc ...

Overseas markets are central to MiniMed’s business, accounting for 70% of reported net sales in the company’s 2026 financial ...

TOLOCHENAZ, SWITZERLAND - Medtronic, Inc. today announced the European launch of MiniMed® Duo(TM), the world's first two-in-one breakthrough that combines a glucose sensor and insulin infusion set ...

Medtronic plc MDT recently achieved the CE Mark for the MiniMed 780G system with Simplera Sync, a disposable, all-in-one continuous glucose monitor (CGM) that does not require any fingersticks or over ...

The Simplera Sync system is designed to be half the size of the company’s previous sensors, and inserted under the skin in less than 10 seconds. (Medtronic) Medtronic has secured a green light from ...

Medtronic launches MiniMed Go Smart MDI with the Simplera sensor in Europe. MDT's MiniMed Go system links InPen and Simplera data in one app with real-time insights and dose alerts. Medtronic's ...

Medtronic (NYSE:MDT) announced on Tuesday that the U.S. FDA cleared its SmartGuard algorithm as an interoperable automated glycemic controller, allowing the integration of its MiniMed 780G insulin ...

Real-time actionable insights on one mobile app for people who manage their diabetes using multiple daily injections GALWAY, Ireland, Feb. 25, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global ...

DUBLIN, Jan. 8, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced CE (Conformité Européenne) Mark approval for the MiniMed™ 780G system with ...